Homology Medicines: Q4 Earnings Snapshot

BEDFORD, Mass. (AP) — BEDFORD, Mass. (AP) — Homology Medicines Inc. (FIXX) on Thursday reported a loss of $34.3 million in its fourth quarter.

The Bedford, Massachusetts-based company said it had a loss of 60 cents per share.

The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 51 cents per share.

The gene editing company posted revenue of $802,000 in the period.

For the year, the company reported that its loss narrowed to $5 million, or 9 cents per share. Revenue was reported as $3.2 million.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FIXX at https://www.zacks.com/ap/FIXX

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up